02575.HK
Xuanzhubio-b
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 10.43
−6.21%Margins
Gross margin
38.8%
EBITDA margin
-392.8%
EBIT margin
-450.8%
Net margin
-474.2%
FCF margin
-398.2%
-27.8%
Return on equity
-21.9%
Return on assets
-26.4%
Return on invested capital
—
Asset turnover
-HKD 223.0M
Cash from operations
HKD 0.48
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025